# Acurx Pharmaceuticals, Inc.: Form S-1, filed Jul 15, 2025

- Company: [Acurx Pharmaceuticals, Inc.](/companies/acxp.md) (CIK 1736243)
- Form: S-1
- Filed: 2025-07-15
- Accepted by EDGAR: Jul 14, 2025, 20:22 ET
- Period: not reported
- Accession: 0001104659-25-067841
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1736243/000110465925067841/tm2520539d1_s1.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1736243/000110465925067841/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1736243/000110465925067841/tm2520539d1_s1.htm

Filed Jul 15, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-067841. Last ingested by Listed: Oct 29, 2026, 17:22 ET. No prices; not investment advice.
